Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Merck & Co., Inc. MRK secured a favorable recommendation from a European regulatory committee for its cancer therapy Keytruda in combination with Padcev to treat adults facing resectable ...

Auxier Asset Management, an investment advisory firm, released its second-quarter 2026 investor letter. The letter can be ...

In early September 2026, Merck & Co., Inc. deepened its innovation push through multiple investor conferences and a new ...

Merck & Co., Inc. (NYSE: MRK) has had a fantastic six months, seeing its share price go up nearly 50%. The company has a valuable portfolio of assets that will enable strong shareholder returns, ...

Drug major Merck & Co., Inc. ( MRK) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending approval of ...

Merck launches Your Hive of Whole Health at USCHA 2026, expanding HIV support across physical, mental, emotional and social well-being needs and care.

Following their blowout win in melanoma last month, Merck and Moderna are leading the way among a new crop of personalized ...

Merck & Co. is turning down its option to license Evaxion’s gonorrhea vaccine candidate, closing the door on the Danish biotech’s chance to collect up to $592 million in biobucks. Evaxion will now ...

A personalized mRNA vaccine developed by Merck & Co., Inc. and Moderna, Inc. has shown positive Phase 3 results in patients with high-risk melanoma, marking a significant milestone in the effort to ...

Providing a diverse range of perspectives from bullish to bearish, 10 analysts have published ratings on Merck & Co (NYSE:MRK) in the last three months. The following table provides a quick overview ...

Interim data from a large trial showed the experimental vaccine, when combined with Merck's blockbuster immunotherapy Keytruda, helped reduce the risk of melanoma recurrence and spread in ‌patients ...